159 related articles for article (PubMed ID: 22331708)
1. Molecular mechanisms in urinary bladder carcinogenesis.
Volanis D; Papadopoulos G; Doumas K; Gkialas I; Delakas D
J BUON; 2011; 16(4):589-601. PubMed ID: 22331708
[TBL] [Abstract][Full Text] [Related]
2. Environmental factors and genetic susceptibility promote urinary bladder cancer.
Volanis D; Kadiyska T; Galanis A; Delakas D; Logotheti S; Zoumpourlis V
Toxicol Lett; 2010 Mar; 193(2):131-7. PubMed ID: 20051252
[TBL] [Abstract][Full Text] [Related]
3. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression.
Quentin T; Henke C; Korabiowska M; Schlott T; Zimmerman B; Kunze E
Anticancer Res; 2004; 24(2B):1011-23. PubMed ID: 15161057
[TBL] [Abstract][Full Text] [Related]
4. [Molecular changes in development and progression of urothelial carcinoma].
Hartmann A
Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910
[TBL] [Abstract][Full Text] [Related]
5. Carcinogen exposure and gene promoter hypermethylation in bladder cancer.
Marsit CJ; Karagas MR; Danaee H; Liu M; Andrew A; Schned A; Nelson HH; Kelsey KT
Carcinogenesis; 2006 Jan; 27(1):112-6. PubMed ID: 15987713
[TBL] [Abstract][Full Text] [Related]
6. Superimposed histologic and genetic mapping of chromosome 9 in progression of human urinary bladder neoplasia: implications for a genetic model of multistep urothelial carcinogenesis and early detection of urinary bladder cancer.
Czerniak B; Chaturvedi V; Li L; Hodges S; Johnston D; Roy JY; Luthra R; Logothetis C; Von Eschenbach AC; Grossman HB; Benedict WF; Batsakis JG
Oncogene; 1999 Feb; 18(5):1185-96. PubMed ID: 10022124
[TBL] [Abstract][Full Text] [Related]
7. Carcinogen exposure and epigenetic silencing in bladder cancer.
Marsit CJ; Karagas MR; Schned A; Kelsey KT
Ann N Y Acad Sci; 2006 Sep; 1076():810-21. PubMed ID: 17119258
[TBL] [Abstract][Full Text] [Related]
8. The p53 tumor suppressor gene and nuclear protein: basic science review and relevance in the management of bladder cancer.
Smith ND; Rubenstein JN; Eggener SE; Kozlowski JM
J Urol; 2003 Apr; 169(4):1219-28. PubMed ID: 12629332
[TBL] [Abstract][Full Text] [Related]
9. Interest of methylated genes as biomarkers in urothelial cell carcinomas of the urinary tract.
Phé V; Cussenot O; Rouprêt M
BJU Int; 2009 Oct; 104(7):896-901. PubMed ID: 19522860
[TBL] [Abstract][Full Text] [Related]
10. Urothelial neoplasms of the urinary bladder occurring in young adult and pediatric patients: a comprehensive review of literature with implications for patient management.
Paner GP; Zehnder P; Amin AM; Husain AN; Desai MM
Adv Anat Pathol; 2011 Jan; 18(1):79-89. PubMed ID: 21169741
[TBL] [Abstract][Full Text] [Related]
11. Deletions of chromosomes 9 and 8p in histologically normal urothelium of patients with bladder cancer.
Stoehr R; Zietz S; Burger M; Filbeck T; Denzinger S; Obermann EC; Hammerschmied C; Wieland WF; Knuechel R; Hartmann A
Eur Urol; 2005 Jan; 47(1):58-63. PubMed ID: 15582250
[TBL] [Abstract][Full Text] [Related]
12. Bladder cancer. I. Molecular and genetic basis of carcinogenesis.
Brandau S; Böhle A
Eur Urol; 2001 May; 39(5):491-7. PubMed ID: 11464028
[TBL] [Abstract][Full Text] [Related]
13. Molecular evidence supporting field effect in urothelial carcinogenesis.
Jones TD; Wang M; Eble JN; MacLennan GT; Lopez-Beltran A; Zhang S; Cocco A; Cheng L
Clin Cancer Res; 2005 Sep; 11(18):6512-9. PubMed ID: 16166427
[TBL] [Abstract][Full Text] [Related]
14. Histogenesis of sarcomatoid urothelial carcinoma of the urinary bladder: evidence for a common clonal origin with divergent differentiation.
Sung MT; Wang M; MacLennan GT; Eble JN; Tan PH; Lopez-Beltran A; Montironi R; Harris JJ; Kuhar M; Cheng L
J Pathol; 2007 Mar; 211(4):420-30. PubMed ID: 17236170
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic alterations in normal bladder epithelium in patients with metachronous bladder cancer.
Muto S; Horie S; Takahashi S; Tomita K; Kitamura T
Cancer Res; 2000 Aug; 60(15):4021-5. PubMed ID: 10945601
[TBL] [Abstract][Full Text] [Related]
16. Molecular alterations associated with bladder cancer initiation and progression.
Cordon-Cardo C
Scand J Urol Nephrol Suppl; 2008 Sep; (218):154-65. PubMed ID: 18815930
[TBL] [Abstract][Full Text] [Related]
17. Molecular pathways of urothelial development and bladder tumorigenesis.
Castillo-Martin M; Domingo-Domenech J; Karni-Schmidt O; Matos T; Cordon-Cardo C
Urol Oncol; 2010; 28(4):401-8. PubMed ID: 20610278
[TBL] [Abstract][Full Text] [Related]
18. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
[TBL] [Abstract][Full Text] [Related]
19. Bladder Cancer Working Group report.
Kakehi Y; Hirao Y; Kim WJ; Ozono S; Masumori N; Miyanaga N; Nasu Y; Yokomizo A
Jpn J Clin Oncol; 2010 Sep; 40 Suppl 1():i57-64. PubMed ID: 20870921
[TBL] [Abstract][Full Text] [Related]
20. Infrequent microsatellite instability in urothelial cell carcinoma of the bladder in young patients.
Mongiat-Artus P; Miquel C; van der Aa M; Buhard O; Hamelin R; Bangma C; Teillac P; van der Kwast T; Praz F
Eur Urol; 2006 Apr; 49(4):685-90. PubMed ID: 16413104
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]